Last reviewed · How we verify

NCT06687148: GCASID

Global Changes Associated With Sacroiliac Joint Dysfunction

Not yet recruiting NA Last updated 9 April 2025
What this trial tests

NA trial testing Manual manipulation in Sacroiliac Dysfunction in 21 participants. Not yet recruiting.

Timeline
1 April 2025
Primary endpoint
30 May 2025
12 June 2025

Quick facts

Lead sponsorAveiro University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment21
Start date1 April 2025
Primary completion30 May 2025
Estimated completion12 June 2025
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Aveiro University

Who can join

Adults 18 to 30, any sex, with Sacroiliac Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Summary Sacroiliac joint dysfunction (ASI) is an alteration in the normal biomechanics of the joint, which leads to hypomobility or hypermobility of that joint. It is one of the most common causes of misdiagnosis in low back pain and when not treated correctly, it often evolves into chronic pain (30% to 42%) and disability. Manipulating the dysfunctional ASI appears to result in benefits and significantly positive changes at various levels, in all segments of the human body. With this investigation, we intend to clarify and deepen the possible correlation between the changes that normally accompany this dysfunction, as well as its possible reversibility with its normalization. * Objectives The investigators will essentially have two main objectives: 1. Mapping of the most evident symptomatic changes, when sacroiliac joint dysfunction is present, in terms of pain and muscle tone; 2. To try to understand the immediate, global and immediate effect of ASI manipulation. * Study design Quantitative, with experimental study design, with the sample comprising individuals with SIJ dysfunction, where all participants will be randomly allocated to the experimental, control and sham groups. It will be carried out at the University of Aveiro facilities. Initially, we will assess the participants with sacroiliac dysfunction. The experimental will be manipulated, the control group will do nothing, and the sham group will be submitted to a hypothetical manipulation (sham manipulation). Consequently, the patients will be assessed again, measuring the subjective and objective degree of pain and muscle tone. \- Material and methods We will make use of: * Standing flexion test; * Sitting Flexion Test; * Faber Test; * EVA , to subjectively assess pain; * Pressure algometer, to objectively assess pain ; * MyotonPro, to assess muscle tone;

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Aveiro University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06687148.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing